ABCAM PLC Annual Financial Report (1836O)
September 30 2019 - 8:35AM
UK Regulatory
TIDMABC
RNS Number : 1836O
ABCAM PLC
30 September 2019
30 September 2019
ABCAM PLC
("Abcam" or "the Company")
Publication of 2019 Annual Report and Accounts
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of life science research tools, announces that its Annual
Report and Accounts for the year ended 30 June 2019 will be
published today on the Company's investor relations website,
www.abcamplc.com.
It will also be posted today, together with the Notice of Annual
General Meeting, to those shareholders that have elected to receive
paper communications. Shareholders that have not elected to receive
paper communications will be notified of the availability of these
documents on the Company's investor relations website,
www.abcamplc.com.
For further information please contact:
Abcam plc + 44 (0) 1223 696 000
Marc Perkins, Company Secretary
James Staveley, Vice President Investor Relations
About Abcam plc
As an innovator in reagents and tools, Abcam's purpose is to
serve life science researchers globally to achieve their mission,
faster. Providing the research and clinical communities with tools
and scientific support, the Group offers highly validated
antibodies and assays to address important targets in critical
biological pathways.
Already a pioneer in data sharing and ecommerce in the life
sciences, Abcam's ambition is to be the most influential company in
life sciences by helping advance global understanding of biology
and causes of disease, which, in turn, will drive new treatments
and improved health.
Some two-thirds of the world's 750,000 life science researchers
use Abcam's antibodies, reagents, biomarkers and assays. By
actively listening to and collaborating with these researchers, the
Group continuously advances its portfolio to address their needs. A
transparent programme of customer reviews and datasheets, combined
with an industry-leading validation initiative, gives researchers
increased confidence in their results.
Founded in 1998 and headquartered in Cambridge, UK, the Company
sells to more than 140 countries. Abcam was admitted to AIM in 2005
(AIM: ABC).
Please visit www.abcam.com or www.abcamplc.com to find out
more.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACSCKKDNBBKDBCN
(END) Dow Jones Newswires
September 30, 2019 08:35 ET (12:35 GMT)
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024